BRIEF published on 08/05/2025 at 17:50, 3 months 30 days ago Lagardère Updates on Share Capital and Voting Rights Share Capital Voting Rights Financial Update LAGARDERE July 2025
REGULATED PRESS RELEASE published on 08/05/2025 at 17:45, 3 months 30 days ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL Lagardère SA reports monthly information on voting rights and share capital in accordance with French regulations Share Capital Voting Rights French Regulations Monthly Information Lagardère SA
BRIEF published on 07/24/2025 at 19:43, 4 months 11 days ago Lagardère SA Releases 2025 Interim Financial Report AMF Regulated Information LAGARDERE Interim Results 2025 Financial Report
REGULATED PRESS RELEASE published on 07/24/2025 at 19:38, 4 months 11 days ago PUBLICATION OF THE INTERIM FINANCIAL REPORT 2025 Lagardère SA releases 2025 Interim Financial Report with activity report and financial statements for the first half of the year Financial Statements Lagardère SA French Financial Markets Authority 2025 Interim Financial Report Half-yearly Financial Information
BRIEF published on 07/24/2025 at 17:40, 4 months 11 days ago Lagardère Group Reports Strong First-Half 2025 Results Revenue Growth Lagardère Travel Retail Deleveraging Recurring EBIT First-half Results
REGULATED PRESS RELEASE published on 07/24/2025 at 17:35, 4 months 11 days ago First-Half 2025 Results Lagardère group reports solid first-half 2025 results with revenue up 3% and recurring EBIT up 6%, driven by all businesses. Deleveraging on track. Chairman Arnaud Lagardère comments on the positive growth Revenue LAGARDERE Deleveraging Recurring EBIT First-half Results
BRIEF published on 07/10/2025 at 17:50, 4 months 25 days ago Lagardère SA Reports Half-Year Liquidity Contract Update Liquidity Contract Half-year Report Lagardère SA BNP Paribas Market Transactions
REGULATED PRESS RELEASE published on 07/10/2025 at 17:45, 4 months 25 days ago Half-year liquidity contract statement French joint-stock corporation, LAGARDÈRE SA, discloses details of liquidity contract with BNP PARIBAS FINANCIAL MARKETS for the first half of 2025 as per French Financial Markets Authority regulations Liquidity Contract Lagardère SA French Financial Markets Authority BNP Paribas Financial Markets
BRIEF published on 07/02/2025 at 17:50, 5 months 2 days ago Lagardère's Share Capital and Voting Rights Update for June 2025 Share Capital Voting Rights French Regulations LAGARDERE June 2025
REGULATED PRESS RELEASE published on 07/02/2025 at 17:45, 5 months 2 days ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL French company Lagardère SA discloses monthly voting rights and share capital information as required by French financial regulations Share Capital Voting Rights Monthly Information Lagardère SA French Financial Regulations
Published on 12/05/2025 at 02:35, 3 hours 53 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 28 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 23 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 28 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 37 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 13 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 17 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 28 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 43 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 44 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 27 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
